PMA device
Cardiowest Temporary Total Artifical Heart (Tah-T) System
Syncardia Systems, LLC · Artificial Heart (LOZ, Class III) · First FDA decision Aug 11, 2008, newest Aug 11, 2008Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
2
Naming "Cardiowest Temporary"
MAUDE reports
0
Brand "Cardiowest Temporary", since 2015
PubMed studies
4
Mentioning "Cardiowest Temporary"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cardiowest Temporary Total Artifical Heart (Tah-T) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P030011-S003 · Decided Aug 11, 2008 · 62 days after receipt · Normal 180 Day Track No User Fee
Device type: Artificial heart (LOZ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Artificial Hearts and related devices, including Ventricular Assist Devices for Bridge-to-Transplant and Destination TherapyNational analysisReview closedCAG-00453NUpdated Nov 19, 2026
- Artificial HeartsNational analysisReview closedCAG-00322NUpdated Sep 16, 2026
- Artificial Hearts and Related Devices - RETIREDNational determinationOn the books20.9Updated Jun 5, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Cardiowest Temporary", any status and sponsor, newest update first.
- SynCardia Freedom Driver System StudyApproved for marketing
SynCardia Systems. LLCNot on our public-company list
NCT00733447 · Start Mar 2010 · Primary completion Aug 2013
Device: CardioWest temporary Total Artificial Heart (TAH-t) System · For: Biventricular Failure
Sites: Phoenix, Arizona; Philadelphia, Pennsylvania; Richmond, Virginia
SynCardia Systems. LLCNot on our public-company list
NCT00614510 · 196 participants · Start Aug 2006 · Primary completion Mar 2015
Device: CardioWest temporary Total Artificial Heart (TAH-t) · For: Biventricular Failure
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cardiowest Temporary", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOZ
3,209 reports: 2,545 malfunction, 279 injury, 384 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0126-2024 · Started Aug 1, 2023 · Posted by FDA Oct 20, 2023
Reason given: Artificial hearts contain a epoxy resin that has not been reviewed by the FDA for safety and efficacy.
Cause as FDA categorized it: Other · Device type: Artificial Heart (LOZ)
- SynCardia Total Artificial Heart System (70CC): 500101-001 SynCardia Total Artificial Heart System (50CC): 570500-000Open, Classified
Z-1022-2023 · Started Nov 2, 2022 · Posted by FDA Jan 27, 2023
Reason given: Due to tears reported tears in the cannula due to wear and tear stress.
Cause as FDA categorized it: Device Design · Device type: Artificial Heart (LOZ)
Z-0659-2017 · Started Oct 21, 2016
Reason given: The Main Printed Circuit Board Assembly (PCBA) of the affected Freedom Drivers may fail and cause the Freedom Driver to stop functioning without visual or audible alarms, resulting in the loss of life-sustaining function.
Cause as FDA categorized it: Process control · Device type: Artificial Heart (LOZ)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Cardiowest Temporary"[tiab]. The summary above synthesizes these.
- CardioWest temporary total artificial heart.
Platis A, Larson DF · Perfusion · 2009Review
- Total artificial heart and physical therapy management.
Nicholson C, Paz JC · Cardiopulm Phys Ther J · 2010
- Antithrombotic therapy for the CardioWest temporary total artificial heart.
Ensor CR, Cahoon WD, Crouch MA, et al. · Tex Heart Inst J · 2010Review
- Triple bridge to simultaneous heart and kidney transplantation.
El-Sayed Ahmed MM, Aftab M, Singh SK, et al. · Ann Thorac Surg · 2014Case Reports
Other devices of this type
Also filed under product code LOZ.
- SynCardia temporary Total Artificial Heart (TAH-t) SystemSyncardia Systems, LLC · PMA 2023
- Total Artificial HeartSyncardia Systems, LLC · PMA 2025
- Syncardia Companion 2 Driver SystemSyncardia Systems, LLC · PMA 2012
- Syncardia Temporary Cardiowest Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2005
- Syncardia Temporary Cardio West Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.